Australasian Society for HIV Viral Hepatitis and Sexual Health Medicine (ASHM), March 2025 The Doxy-PEP Decision Making Tool supports prescribing doxycycline post-exposure prophylaxis (Doxy-PEP) to gay and bisexual men and transgender women at increased risk of syphilis. Suitable patients include those with recent syphilis or other STI diagnoses, periods of increased risk, or who wish to protect...
ASHM, May 2024 Contraception Essentials: Navigating a Consultation is a video resource designed to support clinicians in their contraceptive consultations. The video guides clinicians to utilise ASHM’s Decision Making in Contraception: Consultation Essential resource to conduct patient-centred and evidence-based contraceptive consultations. Through the demonstration consultation, viewers will...
Ylva Odenbring & Lisa Lindén (2023) Gender, sex and equal health: school nurses’ strategies and experiences of including boys in the HPV vaccination programme in Swedish primary schools, Sex Education, 23:5, 617-630, DOI: 10.1080/14681811.2022.2106959 Abstract: Since autumn 2020, boys in the fifth year of school (11-year-old students) in Sweden have been offered human papillomavirus (HPV)...
SHINE SA, June 2022
This Fact Sheet covers genital skin care including how to wash the genitals, vaginal and vulval discharge and irritation, penis hygiene, and balanitis. It has been produced by SHINE SA and is aimed at consumers.
Download fact sheet (PDF) on Genital Skin Care here
Kirby Institute, UNSW, Wednesday, 6 April 2022 The World Health Organization has set an ambitious target to eliminate hepatitis C as a public health threat by 2030. Some countries, including Australia, have made good progress, but if elimination is to be achieved, existing health strategies need to be scaled up and targeted toward the people most at risk, according to new research from the Kirby...
July/August 2020 The Therapeutic Goods Administration (TGA) advises: Consumers and health professionals are advised that there is a shortage of oral contraceptive pills containing the combination ethinylestradiol and norethisterone. The affected products are: Brevinor – norethisterone 0.5 mg and ethinylestradiol 35 micrograms Norimin – norethisterone 0.5 mg and ethinylestradiol 35...